Basic and clinical approach to Turner syndrome : proceedings of the 3rd International Symposium on Turner Syndrome, Chiba, Japan, 8-10 July 1992
著者
書誌事項
Basic and clinical approach to Turner syndrome : proceedings of the 3rd International Symposium on Turner Syndrome, Chiba, Japan, 8-10 July 1992
(International congress series, no. 1014)
Excerpta Medica, 1993
大学図書館所蔵 全9件
  青森
  岩手
  宮城
  秋田
  山形
  福島
  茨城
  栃木
  群馬
  埼玉
  千葉
  東京
  神奈川
  新潟
  富山
  石川
  福井
  山梨
  長野
  岐阜
  静岡
  愛知
  三重
  滋賀
  京都
  大阪
  兵庫
  奈良
  和歌山
  鳥取
  島根
  岡山
  広島
  山口
  徳島
  香川
  愛媛
  高知
  福岡
  佐賀
  長崎
  熊本
  大分
  宮崎
  鹿児島
  沖縄
  韓国
  中国
  タイ
  イギリス
  ドイツ
  スイス
  フランス
  ベルギー
  オランダ
  スウェーデン
  ノルウェー
  アメリカ
注記
Includes bibliographical references and index
内容説明・目次
内容説明
A lot of progress has been made in the field of genetics, pathophysiology and treatment of patients with Turner syndrome over the past couple of years. The International Symposium on Turner Syndrome was organized with a view to bringing together researchers throughout the world to facilitate exchange of their knowledge and most recent findings. In total, 45 papers were presented, covering genetics, natural history, endocrine function, bone metabolism, psychosocial problems, growth factors and various kinds of treatment. This publication should serve as a useful guide for Turner patients, researchers and physicians.
目次
Genetics: Prevalence of Turner syndrome in Japan (K. lmaizumi, Y- Kuroki). Mechanisms leading to statural changes in patients with sex chromosome aberrations (T. Ogata, N Marsuo). Genotype-phenotype correlations in the Turner syndrome (M.A. Ferguson-Smith). From chromosomes and genes to the discovery of Turner syndrome secrets (M. L, Giovannucci Uzielli, M. Failli, C. Siondi). Mapping the human Y chromosome (Y. Nakagome, S. Nagafuchi. Y. Nakahori). Neoplasia in Turnersyndrome(A,A. Sandborg). Turner syndrome and the Y chromosome (A.R. Zinn, D.C. Paqe). Chairperson's comments. Natural History (Growth and Organogenesis): Structural defects of the vascular system in 45, X fetuses: Integrated interpretation of the pathogenesis (S. Miyabara et al.). standards for growth and growth velocity in Turner syndrome (S. Suwa). Growth in Turner syndrome: Updating the United States experience (B. Lippe et al,). Reference values for spontaneous growth in Turner girls and its use in estimating treatment effects (J. Karlberg et al.). The natural history of ovarian demise in Turner syndrome (R. Stanhope,A. Massarano, C.G.D. Brook). The pregnancy outcome of Turner syndrome: Case report and review of the literature (S. Kawagoe, N. Kaneko, M Hiroi). Glucose tolerance in Turner syndrome" (T. Tanaka et al.). Chairperson's comments. Endocrine Function and Bone Metabolism: Ovarian functic)n in Turner syndrome: Recognizing the spectrum (B. Lippe, S.J. Westra, M.I. Boechat). Hormonal characteristics of the menstrual cycle in Turner syndrome (H. Maesaka et al.). Thyroid function in Turner syndrome (G. Massa, F. de Zogher, M. Vanderschueren-Lodeweyckx). Calcium and bone metabolism in Ullrich-Turner syndrome before and during HGH treatment (K. Kruse, E. Schdnau). Biglycan synthesis in fibroblasts of patients with Turner syndrome and other sex chromosome anomalies (U. Vetteretal.). Skeletal growth in the Turner syndrome: Cellularand molecular pathogenetic considerations (W.A. Horton). Chairperson's comments. Psychosocial problems: Psychosocial functioning and effects of growth hormone treatment in Tumer syndrome (J. Huisman et al.). Psychosocial functioning in middle-aged women with Turner syndrome (L. Sylven et al.). What more can be done for girls and women with Tumer syndrome (J Nielsen). Follow-up study of 69 Turner women (B. Konradsen, J. Ivielsen). Benefits of support groups for those affected by Turner syndrome and the associated medical community (L.G . Tesch). Chairperson's comments. Gonadal replacement therapy: Treatment of Turner syndrome with transdermal estradiol (Estraderm) (Y. Igarashi et al.). A multi-centre double-blind trial of synthetic growth hormone and low dose oestrogen in Turner syndrome: Two year analysis (G.A. Werther, J. Simpson). Treatment in Turner syndrome with a low dose of peroral 17-B-estradiol alone, or in combination with growth hormone (R.W. Naeraa, K.W. Kastrup, J. Nielsen). Part contents.
「Nielsen BookData」 より